LUDIOMIL TAB 50MG 50 MG
MAPROTILINE HYDROCHLORIDE : 50 MG · DIN 00360503 · NOVARTIS PHARMACEUTICALS CANADA INC
Health Canada status: CANCELLED POST MARKET
What is LUDIOMIL TAB 50MG?
LUDIOMIL TAB 50MG 50 MG contains MAPROTILINE HYDROCHLORIDE : 50 MG. It is listed in the Health Canada Drug Product Database under DIN 00360503, held by NOVARTIS PHARMACEUTICALS CANADA INC, supplied as TABLET for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 30-Jul-2001. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 00360503 |
|---|---|
| Brand name | LUDIOMIL TAB 50MG |
| Generic / active ingredient | MAPROTILINE HYDROCHLORIDE : 50 MG |
| Manufacturer | NOVARTIS PHARMACEUTICALS CANADA INC |
| Strength | 50 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | N06AA21 MAPROTILINE |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 30-Jul-2001 |
What can be used instead?
Other Canadian products sharing ATC code N06AA21 MAPROTILINE. 0 of 12 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| LUDIOMIL TAB 10MG | 10 MG | TABLET | NOVARTIS PHARMACEUTICALS CANADA INC | CANCELLED POST MARKET | DIN 00641855 |
| LUDIOMIL TAB 25MG | 25 MG | TABLET | NOVARTIS PHARMACEUTICALS CANADA INC | CANCELLED POST MARKET | DIN 00360481 |
| LUDIOMIL TAB 75MG | 75 MG | TABLET | NOVARTIS PHARMACEUTICALS CANADA INC | CANCELLED POST MARKET | DIN 00360511 |
| NOVO-MAPROTILINE - TAB 10MG | 10 MG | TABLET | NOVOPHARM LIMITED | CANCELLED POST MARKET | DIN 02158604 |
| PMS-MAPROTILINE | 10 MG | TABLET | PHARMASCIENCE INC | CANCELLED PRE MARKET | DIN 02231559 |
| PMS-MAPROTILINE | 25 MG | TABLET | PHARMASCIENCE INC | CANCELLED PRE MARKET | DIN 02231560 |
| PMS-MAPROTILINE | 50 MG | TABLET | PHARMASCIENCE INC | CANCELLED PRE MARKET | DIN 02231561 |
| PMS-MAPROTILINE | 75 MG | TABLET | PHARMASCIENCE INC | CANCELLED PRE MARKET | DIN 02231562 |
| TEVA-MAPROTILINE | 25 MG | TABLET | TEVA CANADA LIMITED | CANCELLED POST MARKET | DIN 02158612 |
| TEVA-MAPROTILINE | 50 MG | TABLET | TEVA CANADA LIMITED | CANCELLED POST MARKET | DIN 02158620 |
Who else supplies MAPROTILINE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. MAPROTILINE appears in 8 registered pack listings across 3 markets, published on 3 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.